Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

SymBio begins Japanese phase II trial of SyB L-0501 for new indication

Nov. 11, 2011

Merck & Co. discloses new protein kinase inhibitors

Nov. 11, 2011

MIT discloses novel targeted siRNA nanocomplexes for ovarian cancer

Nov. 10, 2011

Peking University synthesizes novel agents to treat cancer

Nov. 10, 2011

New tranylcypromine derivatives designed in Italy

Nov. 10, 2011

Novel antitumor compound prepared at Chinese university

Nov. 10, 2011

Enrollment begins in Genetech's phase II GDC-0980 trial in endometrial cancer

Nov. 10, 2011

Recommended phase II dose of serdemetan determined in patients with advanced solid tumors

Nov. 10, 2011

Aspirin lowers risk of colorectal cancer in Lynch syndrome

Nov. 10, 2011

FDA accepts NDA for vismodegib

Nov. 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...